Social networks
135 1,149Activities
Technologies
Entity types
Location
Dr.-Bohr-Gasse 7, 1030 Wien, Austria
Wien
Austria
Employees
Scale: 2-10
Estimated: 15
Engaged corporates
1Added in Motherbase
1 year, 2 months agoDiscovery and development of novel therapeutics targeting transcription factors in cancer and other diseases
QUANTRO Therapeutics (“QUANTRO”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. QUANTRO will assemble a highly innovative drug-discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. The first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. QUANTRO was founded as a spin-off of the Institute of Molecular Biotechnology (“IMBA”) and the Research Institute of Molecular Pathology (“IMP”), both located in Vienna, Austria.
Pharmaceuticals, Startup, Drug Discovery, Vienna BioCenter, Biotech, and Therapeutics
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 31 Jul 2022 | |